- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- On-Demand
Episode 1 of 4 - The Evolution of Biomarker Testing: Revolutionizing Treatment of NSCLC
- Part of the Series: NSCLC
- Available: November 22, 2022 —
- November 28, 2023
- Credit: 0.30hr(s)
- Credit Types: NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Location: Internet Activity Enduring
Course Description
Biomarker testing can have a significant impact on the treatment plan of patients with non-small cell lung cancer (NSCLC). In this first episode of the 4-part educational initiative Biomarker-based Therapy for NSCLC: Improving Collaboration, Communication, and Care, expert faculty apply the latest clinical guidelines and give practical tips on breaking down barriers for oncology teams to successfully implement biomarker testing for NSCLC patients, including those in underserved populations.
Other Courses in this Series
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.30hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: NSCLC
- Expires: February 16, 2024
- Credit: 0.50hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: NSCLC, Oncology
- Series: NSCLC
- Expires: February 16, 2024
- Credit: 0.50hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: NSCLC, Oncology
Other Courses That May be of Interest
- Series: RRMM
- Expires: February 8, 2024
- Credit: 0.50hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Multiple Myeloma
- Expires: February 28, 2024
- Credit: 1.0hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Hematology
- Specialties: CAR T-Cell Therapy, Lymphoma
- Series: RRMM
- Expires: February 8, 2024
- Credit: 0.50hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Multiple Myeloma
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC